Hubert Department of Global Health Faculty

BACK TO LISTINGS

Carlos Del Rio  

Updated: 08/26/2013    [update]
Professor and Chair (Graduate Faculty)

Hubert Chair and Professor of Global Health
Professor of Medicine (Infectious Diseases)
co-Director, Emory Center for AIDS Research


Department of:
Hubert Department of Global Health

1518 Clifton Road, NE Room 7011
Atlanta, GA 30322
cdelrio@emory.edu
tel: 404-727-1557
fax: 404-727-1278

MD, 1983, Universidad La Salle
 
Additional Appointment(s):
Department of Medicine
 
Courses Taught:
GH 511: Intl Infectious Diseases
 
Career Overview:

Current Titles and Affiliations:

a.         Academic appointments:

April 1st, 2009 - preent – Hubert Professor and Chair, Rollins School of Public Health

Sept 1st, 2003 – Professor of Medicine (Infectious Diseases), Emory University School of Medicine

 

b.                   Clinical Appointments:

Jaun 1st, 2007 – present: Clinical Research Site (CRS) Director for the Emory ACTG, Ponce de Leon Center of the Grady Health System.

 

c.                   Other administrative appointments:

Oct 1st, 2005 – present: Co-Director, Emory Center for AIDS Research.

 

 

 

 
Areas of Interest/Research:
Global Health
HIV/AIDS
Infectious Disease
Public Health Preparedness
Vaccines
 
Selected Research Projects:

 

 

 

  • NIH (2P30 AI 50409-09). Emory CFAR. (PI: JW. Curran, Co-PI C. del Rio) 08/01/07 – 7/31/12.
  • NIH (D43 TW01042-06). Emory AIDS International Training and Research Program (PI: C. del Rio), 06/01/04 - 05/31/09.
  • CDC, Current Trends in Gonococcal Antimicrobial Resistance - GISP (PI: del Rio, C.), 04/01/07 - 3/31/08. 
  • NIH (D43 TW007124). Emory-Georgia Tuberculosis Research Training Program (PI: H. Blumberg; Co-PI: del Rio, C), 09/30/04 - 09/29/09. 
  • NIH/NIDA (RO1 DA017612-1A2). Prevention among HIV+ Crack Users in the Hospital (PI: Metsch L; Co-PI: del Rio C)
  • NIH/NIAID (AI069418). Emory HIV Clinical Trials Unit.  (PI: J. Lennox; CRS leader: C. del Rio) 12/1/06 – 11/30/13

      Industry funded:

·         Merck 023: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Phase II Proof-of-Concept Study to Evaluate the Safety and Efficacy of a 3-Dose Regimen of the Merck Adenovirus Serotype 5 HIV-1 Vaccine gag/pol/nef (MRKAd5 HIV-1gag/pol/nef) in Adults at High Risk of HIV-1 Infection (PI: del Rio), 1/13/05 – 1/13/11

 

 

 
Selected Publications:
Copeland B, Shah B, Wheatley M, Heilpern K,
Del Rio, C
.
, Houry D
Diagnosing HIV in men who have sex with men: an emergency department experience
AIDS Patient Care STDS
, 2012.
http://www.ncbi.nlm.nih.gov/pubmed/22356726
 
Bonney LE, Cooper HL, Caliendo AM,
Del Rio, C
.
, Hunter-Jones J, Swan DF, Rothenberg R, Druss B.
Access to health services and sexually transmitted infections in a cohort of relocating African American public housing residents: an association between travel time and infection
Sex Transm Dis.
, 39: 116-21, 2012.
http://www.ncbi.nlm.nih.gov/pubmed/22249300
 
Doshi RK, Vogenthaler N, Lewis S, Rodriguez A, Metsch L,
Del Rio, C

Correlates of antiretroviral utilization among hospitalized HIV-infected crack cocaine users
AIDS Res Hum Retroviruses.
, 2012.
http://www.ncbi.nlm.nih.gov/pubmed/22214200
 
Hogan CM, Degruttola V, Sun X, Fiscus SA,
Del Rio, C
.
, Hare CB, Markowitz M, Connick E, Macatangay B, Tashima KT, Kallungal B, Camp R, Morton T, Daar ES, Little S; A5217 Study Team.
The Set Point Study (ACTG A5217): effect of immediate vs. deferred antiretroviral therapy on virologic set point in recently HIV-infected individuals
J Infect Dis.
, 205: 87-96, 2012.
http://www.ncbi.nlm.nih.gov/pubmed/22180621
 
Steinau M, Reddy D, Sumbry A, Reznik D, Gunthel CJ,
Del Rio, C
.
, Lennox JL, Unger ER, Nguyen ML.
Oral sampling and human papillomavirus genotyping in HIV-infected patients
J Oral Pathol Med. 2011
, 2011.
http://www.ncbi.nlm.nih.gov/pubmed/22082117
 
Del Rio, C
.
, Armstrong W.
Antiretroviral therapy programmes in resource limited settings
BMJ
, 2011.
http://www.ncbi.nlm.nih.gov/pubmed/22074712
 
Talati NJ, Gonzalez-Diaz E, Mutemba C, Wendt J, Kilembe W, Mwananyanda L, Chomba E, Allen S,
Del Rio, C
.
, Blumberg HM
Diagnosis of latenttuberculosis infection among HIV discordant partners using interferon gamma release assays
BMC Infect Dis.
, 11: 264, 2011.
http://www.ncbi.nlm.nih.gov/pubmed/21962029
 
Narayan KM, Ali MK,
Del Rio, C
.
, Koplan JP, Curran J.
Global noncommunicable diseases - lessons from the HIV-AIDS Experience
N Engl J Med.
, 365: 876-8, 2011.
http://www.ncbi.nlm.nih.gov/pubmed/21899448
 
Rebolledo P, Kourbatova E, Rothenberg R,
Del Rio, C
.
Factors associated with utilization of HAART amongsthard-to-reach HIV-infected individuals in Atlanta, Georgia
J AIDS HIV Res.
, 3: 63-70, 2011.
http://www.ncbi.nlm.nih.gov/pubmed/21866279
 
Dionne-Odom J, Tambe P, Yee E, Weinstock H,
Del Rio, C
.
Antimicrobial resistant gonorrhea in Atlanta: 1988 - 2006
Sex Transm Dis.
, 38: 780-782, 2011.
http://www.ncbi.nlm.nih.gov/pubmed/21844728
 
Del Rio, C
.
Latinos and HIV care in theSoutheastern United States: new challanges complicating longstanding problems
Clin Infect Dis.
, 53: 488-9, 2011.
http://www.ncbi.nlm.nih.gov/pubmed/21844032
 
Curriculum Vitae
 
Link to this page: http://www.sph.emory.edu/faculty/cdelrio